BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4
26 results:

  • 1. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies.
    Mogal MR; Jame JA; Sohel M; Mozibullah M; Mahmod MR; Junayed A; Kar N; Arbia L; Al Mamun A; Sikder MA
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2059. PubMed ID: 38639039
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive pancreatic Ductal Adenocarcinoma.
    Matsumoto M; Shirai Y; Abe K; Futagawa Y; Haruki K; Furukawa K; Onda S; Hamura R; Tanji Y; Tsunematsu M; Shiozaki H; Okamoto T; Ikegami T
    Anticancer Res; 2024 Apr; 44(4):1695-1702. PubMed ID: 38537987
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
    Kaçaroğlu D; Yaylacı S; Gurbuz N
    Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.
    Li A; Li Y; Li Y; Zhang M; Zhang H; Chen F
    PeerJ; 2023; 11():e16243. PubMed ID: 37868053
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes.
    Thorlacius-Ussing J; Jensen C; Nissen NI; Cox TR; Kalluri R; Karsdal M; Willumsen N
    J Pathol; 2024 Jan; 262(1):22-36. PubMed ID: 37728068
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
    Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
    Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation.
    Javanshir HT; Malekraeisi MA; Ebrahimi SSS; Bereimipour A; Kashani SF; Bostaki AA; Mahmoodzadeh H; Nayernia K
    J Med Life; 2022 Sep; 15(9):1143-1157. PubMed ID: 36415513
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
    Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
    Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
    Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
    J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MALDI-MSI: A Powerful Approach to Understand Primary pancreatic Ductal Adenocarcinoma and Metastases.
    Gonçalves JPL; Bollwein C; Schlitter AM; Kriegsmann M; Jacob A; Weichert W; Schwamborn K
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956764
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3.
    Wang Y; Zhang R; Li J; Han X; Lu H; Su J; Liu Y; Tian X; Wang M; Xiong Y; Lan T; Zhang G; Liu Z
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1712-1731. PubMed ID: 35833537
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effects of interobserver and interdisciplinary segmentation variabilities on CT-based radiomics for pancreatic cancer.
    Wong J; Baine M; Wisnoskie S; Bennion N; Zheng D; Yu L; Dalal V; Hollingsworth MA; Lin C; Zheng D
    Sci Rep; 2021 Aug; 11(1):16328. PubMed ID: 34381070
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells.
    Tian C; Huang Y; Clauser KR; Rickelt S; Lau AN; Carr SA; Vander Heiden MG; Hynes RO
    Nat Commun; 2021 Apr; 12(1):2328. PubMed ID: 33879793
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking.
    Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z
    Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis.
    Wang W; Xing H; Huang C; Pan H; Li D
    Med Oncol; 2020 Mar; 37(4):33. PubMed ID: 32200436
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.
    Steins A; van Mackelenbergh MG; van der Zalm AP; Klaassen R; Serrels B; Goris SG; Kocher HM; Waasdorp C; de Jong JH; Tekin C; Besselink MG; Busch OR; van de Vijver MJ; Verheij J; Dijk F; van Tienhoven G; Wilmink JW; Medema JP; van Laarhoven HW; Bijlsma MF
    EMBO Rep; 2020 May; 21(5):e48780. PubMed ID: 32173982
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors.
    Leask A
    Semin Cell Dev Biol; 2020 May; 101():111-114. PubMed ID: 31708414
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
    Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
    Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees.
    Wani S; Han S; Simon V; Hall M; Early D; Aagaard E; Abidi WM; Banerjee S; Baron TH; Bartel M; Bowman E; Brauer BC; Buscaglia JM; Carlin L; Chak A; Chatrath H; Choudhary A; Confer B; Coté GA; Das KK; DiMaio CJ; Dries AM; Edmundowicz SA; El Chafic AH; El Hajj I; Ellert S; Ferreira J; Gamboa A; Gan IS; Gangarosa L; Gannavarapu B; Gordon SR; Guda NM; Hammad HT; Harris C; Jalaj S; Jowell P; Kenshil S; Klapman J; Kochman ML; Komanduri S; Lang G; Lee LS; Loren DE; Lukens FJ; Mullady D; Muthusamy RV; Nett AS; Olyaee MS; Pakseresht K; Perera P; Pfau P; Piraka C; Poneros JM; Rastogi A; Razzak A; Riff B; Saligram S; Scheiman JM; Schuster I; Shah RJ; Sharma R; Spaete JP; Singh A; Sohail M; Sreenarasimhaiah J; Stevens T; Tabibian JH; Tzimas D; Uppal DS; Urayama S; Vitterbo D; Wang AY; Wassef W; Yachimski P; Zepeda-Gomez S; Zuchelli T; Keswani RN
    Gastrointest Endosc; 2019 Jun; 89(6):1160-1168.e9. PubMed ID: 30738985
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.